Do These 4 Factors Support Vivus?

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

With shares of Vivus (NASDAQ:VVUS) trading around $11.08, is VVUS an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

C = Catalyst for a Stock’s Movement

Vivus is a biopharmaceutical company that is aiming to develop medication for obesity, sleep apnea, diabetes and male sexual health. All of these issues are very relevant in society today, so they are definitely researching the right fields at the right time. In order for this company to be successful, it must develop products that successfully address the targeted illnesses. If it is able to execute correctly, look for Vivus to reap huge profits as people look for solutions to these problems.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

T = Technicals on the Stock Chart are Mixed

Like many biopharmaceutical companies, Vivus has seen its fair share of ups and downs. It made highs in the 1990s near $42 per share but later gave most gains back as it traded wildly between the $2 and $10 range for years. The stock broke out of this range last year and skyrocketed towards $30 only to give most of its gains back again. Vivus stock saw a nice uptrend consisting of higher highs and higher lows, and it is currently trading near the last breakout area. Can this price level hold? Let’s find out…

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business